|
Market Closed -
NYSE
00:00:02 10/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 44.02 USD | +2.97% |
|
-0.68% | -53.83% |
| 11-07 | Boston Scientific Neuromodulation Corporation Announces Nalu Td2 Therapy Disc Recall | CI |
| 11-03 | Blackstone Life Sciences, Boston Scientific to Co-Fund Heart Pump | MT |
| Market Cap | 63.81B 56.95B 52.41B 47.56B 90.14B 5,981B 92.38B 627B 250B 3,202B 239B 234B 10,085B | P/E 2026 * |
18x | P/E 2027 * | 19.2x |
|---|---|---|---|---|---|
| Enterprise Value | 74.29B 66.31B 61.02B 55.38B 105B 6,963B 108B 730B 291B 3,728B 279B 273B 11,742B | EV / Sales 2026 * |
3.54x | EV / Sales 2027 * | 3.41x |
| Free-Float |
82.48% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BSX | Delayed | |
CBOE
| BSX | Real-time | |
|
Tradegate
| BSX | Real-time | |
|
London S.E.
| 0HOY | Delayed | |
|
Boerse Muenchen
| BSX | Real-time | |
|
Xetra
| BSX | Delayed | |
|
Börse Stuttgart
| BSX | Delayed | |
|
CBOE
| Real-time | ||
|
Mexican S.E.
| BSX * | End-of-day quote | |
|
Borsa Italiana
| 1BSX | End-of-day quote | |
|
Wiener Boerse
| BSXC | End-of-day quote | |
|
Deutsche Boerse AG
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
CBOE
| 0HOY | Real-time | |
|
Bulgaria S.E.
| BSX | End-of-day quote |
Last Transcript: Boston Scientific Corporation
| 1 day | +2.97% | ||
| 1 week | -0.68% | ||
| Current month | +4.86% | ||
| 1 month | +3.02% | ||
| 3 months | -10.73% | ||
| 6 months | -18.38% | ||
| Current year | -53.83% |
| 1 week | 42.69 |  | 46.97 |
| 1 month | 39.57 | | 46.97 |
| Current year | 39.57 | | 100.9 |
| 1 year | 39.57 | | 105.65 |
| 3 years | 39.57 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 01/11/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 30/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 03/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 01/03/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 15/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/4/26 A | Don | Chief Executive Officer | 252,241 | 0.0171% | ||
| 11/1/26 A | Exercice | Head of Human Resources | 9,614 | 0.0007% | ||
| 8/25/26 A | Buy | Director | 2,040 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.97% | -0.68% | -55.99% | -14.41% | 61.96B | |
| +3.87% | +5.71% | +26.07% | +62.43% | 257B | |
| +2.12% | +3.14% | +11.99% | +20.25% | 162B | |
| +1.71% | +5.42% | -17.76% | +69.07% | 157B | |
| +2.52% | +12.28% | +25.57% | +61.96% | 58.73B | |
| -3.36% | -0.55% | -0.30% | -10.70% | 55.42B | |
| +3.10% | +4.76% | +22.78% | +67.23% | 49.27B | |
| +0.88% | -0.20% | +3.91% | +83.91% | 49.18B | |
| +4.17% | +6.04% | +28.25% | +88.36% | 44.96B | |
| +2.00% | +5.63% | +15.03% | +23.01% | 37.25B | |
| Average | +2.00% | +4.03% | +5.96% | +45.11% | 93B | |
| Weighted average by Cap. | +2.37% | +4.40% | +7.53% | +47.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 20.97B 18.72B 17.22B 15.63B 29.62B 1,965B 30.36B 206B 82.12B 1,052B 78.7B 77.02B 3,314B | 20.88B 18.64B 17.15B 15.56B 29.49B 1,957B 30.23B 205B 81.76B 1,048B 78.36B 76.69B 3,300B |
| Net income | 3.53B 3.15B 2.9B 2.63B 4.99B 331B 5.11B 34.7B 13.83B 177B 13.26B 12.97B 558B | 3.27B 2.92B 2.69B 2.44B 4.62B 307B 4.74B 32.14B 12.81B 164B 12.28B 12.02B 517B |
| Net Debt | 10.48B 9.36B 8.61B 7.82B 14.81B 983B 15.18B 103B 41.06B 526B 39.35B 38.51B 1,657B | 7.39B 6.59B 6.07B 5.51B 10.44B 693B 10.7B 72.59B 28.93B 371B 27.73B 27.14B 1,168B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/11/26 | $44.02 | +2.97% | 16,193,563 |
| 06/11/26 | $42.75 | -4.23% | 14,712,591 |
| 05/11/26 | $44.64 | -2.58% | 22,492,478 |
| 04/11/26 | $45.82 | +5.33% | 34,559,158 |
| 03/11/26 | $43.50 | -1.85% | 18,889,704 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
